CRM logo

PZ Cormay S.A. Stock Price

WSE:CRM Community·zł33.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CRM Share Price Performance

zł0.40
-0.04 (-9.95%)
zł0.40
-0.04 (-9.95%)
Price zł0.40

CRM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

2 Risks
1 Reward

PZ Cormay S.A. Key Details

zł95.5m

Revenue

zł59.9m

Cost of Revenue

zł35.6m

Gross Profit

zł37.9m

Other Expenses

-zł2.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.028
37.27%
-2.48%
0%
View Full Analysis

About CRM

Founded
1985
Employees
823
CEO
Flavio Finotello
WebsiteView website
cormay.com

PZ Cormay S.A., a diagnostic company, provides IVD solutions in Poland and internationally. The company offers analyzers, reagents, cleaning liquids, calibrators, control materials, patterns, and agglutination tests. It also provides analyzers, test strips, inspections, and calibration strips. In addition, the company offers parasitology, such as Paragreen Mini-System, a specialized device for concentrating and preserving stool samples, as well as veterinary medicines. Further, it provides immunochemistry, including SNIBE, MINDRAY, DIESSE, and AliveDX, as well as molecular biology, such as RT-PCR systems, systems for isolating genetic material, workstations, RT-PCR reagent kits, and nucleic acid isolation reagent kits. Additionally, the company offers sampling comprising blood and urine samples and supporting materials, as well as Sentimag systems, Magtrace markers, Magseed Markers, and surgical instruments, as well as HPLC systems, point of care diagnostics, and integrated systems. The company was founded in 1985 and is based in Lomianki, Poland.

Recent CRM News & Updates

Recent updates

No updates